Recent studies have also associated APRIL with insulin resistance, lipolysis, brown adipose tissue dependent thermogenesis and nonalcoholic fatty liver disease, suggesting a broader involvement in energy metabolism [28,30]. Here, TNFSF13 is linked to metabolic dysfunction-associated steatotic liver disease.